About 1.4 million hernia repair operations are performed globally annually. A hernia is a defect in the abdominal wall through which the internal organs may protrude with only the skin as a cover. Complications may arise post-operatively, including rejection of the mesh that is used to repair the defect. Kerecis provides a unique abdominal wall reconstruction material that is re-vascularized and provides strong repair hold, a promise for patients with challenging hernias.

Every year about 34.5 million chronic wounds are treated globally. Kerecis is committed to the prevention and treatment of chronic wounds - that often are the consequence of diabetes and circulation complications. Chronic wounds cause patients severe emotional and physical stress and create a significant financial burden on patients and the whole healthcare system. In the chronic wound the balance between production and degradation of molecules is lost and degradation plays too large a role. Kerecis helps wound regain balance and heal.